Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue The Lancet Neurology Année : 2010

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study

Dates et versions

hal-02640359 , version 1 (28-05-2020)

Identifiants

Citer

Samantha Jilek, Emilie Jaquiéry, Hans Hirsch, Andreas Lysandropoulos, Mathieu Canales, et al.. Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study. The Lancet Neurology, 2010, 9 (3), pp.264-272. ⟨10.1016/S1474-4422(10)70006-5⟩. ⟨hal-02640359⟩
13 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More